Mycophenolate Mofetil Sandoz

Mycophenolate Mofetil, the active ingredient in Mycophenolate Mofetil Sandoz, is an antimetabolite immunosuppressant presented as an oral tablet for oral use. It works by inhibiting lymphocyte proliferation and is employed to prevent organ transplant rejection in adult patients. GNH USA supplies Mycophenolate Mofetil Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Mycophenolate Mofetil is an antimetabolite immunosuppressant used to reduce immune‑mediated rejection in solid‑organ transplantation. - Kidney transplant: lowers the incidence of acute rejection episodes. - Heart transplant: helps maintain graft function and reduces rejection risk. - Liver transplant: decreases the frequency of rejection episodes and supports long‑term graft survival.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: frequent loose stools, may lead to dehydration. - Headache: transient, often resolves with continued use. - Leukopenia: reduced white‑blood‑cell count, increasing infection risk.

Serious or Rare Side Effects: - Opportunistic infections: severe infections due to immune suppression. - Severe neutropenia: markedly low neutrophil counts requiring medical intervention. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Progressive multifocal leukoencephalopathy (PML): rare viral brain infection. - Malignancy: increased long‑term risk of certain cancers.

Before initiating therapy, clinicians should assess baseline laboratory values and consider patient‑specific factors. - Monitor blood counts: perform regular CBC to detect leukopenia or neutropenia. - Assess renal function: adjust dose if creatinine clearance is reduced. - Avoid live vaccines: risk of uncontrolled infection while immunosuppressed. - Pregnancy considerations: discuss potential risks with a healthcare provider. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Mycophenolate Mofetil can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Cyclosporine: increases mycophenolate exposure, raising toxicity risk. - Tacrolimus: synergistic immunosuppression may lead to excessive suppression. - Antacids containing aluminum or magnesium: reduce mycophenolate absorption.

Moderate Interactions (Monitor Closely): - Azathioprine: additive bone‑marrow suppression, monitor blood counts. - Rifampin: induces metabolism, decreasing mycophenolate levels. - Vaccines: monitor immune response and infection risk.